Literatur
Alsaeedi A, Sin DD, McAlister FA (2002) The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 113: 59–65
Burge PS, Calverley PMA, Jones PW et al. (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructiv pulmonary disease: the ISOLDE trial. BMJ 320: 1297–303
Sin DD, Tu JV (2001) Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 580–584
Sin D D, Wu L, Anderson J A et al. (2005) Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 60: 992–997
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung/en hin: Der Autor bezieht Referentenhonorare von GlaxoSmithKline, Astra Zeneca, Novartis und Medac.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamm, H. Chronisch obstruktive Lungenerkrankung. Pneumologe 4, 351–353 (2007). https://doi.org/10.1007/s10405-007-0167-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-007-0167-7